SENSEX
NIFTY
GOLD
USD/INR

Weather

image 23    C

Economy News

The Economic Times

Economy / The Economic Times

details

Semaglutide race: Torrent grabs 38% market share

Over a dozen Indian companies have launched generic versions of the GLP1 drug used for diabetes and weight management since the expiry of Novo Nordisk's patent for the innovator molecule in end-March. They generated about 44 crore in generic semaglutide sales in April.

8 May 2026 12:56 am